Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). The Company’s initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis, and Friedreich’s ataxia.
Type | Public | |
Founded | 2014 | |
HQ | Cambridge, MA, US | Map |
Website | voyagertherapeutics.com | |
Employee Ratings | More |
USD | |
---|---|
Revenue (FY, 2020) | 171.1m |
Net income (FY, 2020) | 36.7m |
EBIT (FY, 2020) | 27.4m |
Market capitalization (13-May-2022) | 244.8m |
Closing stock price (13-May-2022) | 6.4 |
Cash (31-Dec-2020) | 104.4m |
EV | 144.6m |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.9m | 4.8m | 3.7m | 3.3m | 1.5m | 1.2m | 1.1m | 942.0k | 2.6m | 2.1m | 5.2m | 46.1m | 20.4m | 18.1m | 28.7m |
General and administrative expense | 2.5m | 3.6m | 2.9m | 3.4m | 4.9m | 4.5m | 4.9m | 7.2m | 11.8m | 6.6m | 9.7m | 8.3m | 8.5m | 10.2m | 8.2m |
R&D expense | 6.5m | 8.7m | 10.5m | 10.3m | 14.1m | 15.3m | 19.6m | 14.9m | 16.5m | 16.6m | 24.8m | 28.6m | 29.8m | 32.3m | 29.4m |
Operating expense total | 9.0m | 12.3m | 13.3m | 13.7m | 19.0m | 19.8m | 24.5m | 22.0m | 28.3m | 23.2m | 34.5m | 36.9m | 38.2m | 42.5m | 37.7m |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 66.5m | 33.9m | 67.0m | 63.5m | 43.6m | 66.3m | 48.2m | 140.4m | 59.6m | 42.1m | 113.3m | 79.9m | 82.6m | 165.2m | 144.3m |
Prepaid Expenses | 942.0k | 1.7m | 1.5m | 1.9m | 3.4m | 3.4m | 2.6m | 2.4m | 4.1m | 2.9m | 6.7m | 3.3m | 6.2m | 5.3m | 4.3m |
Current Assets | 108.6m | 205.7m | 205.5m | 193.0m | 161.1m | 144.7m | 128.2m | 220.6m | 200.2m | 182.5m | 365.2m | 340.8m | 327.6m | 272.5m | 246.7m |
PP&E | 3.3m | 3.6m | 3.6m | 4.3m | 10.1m | 10.7m | 10.6m | 11.5m | 12.2m | 12.5m | 13.1m | 14.5m | 15.3m | 18.6m | 20.2m |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (22.4m) | (7.2m) | (16.5m) | (25.5m) | (16.6m) | (35.5m) | (58.9m) | (19.9m) | (45.5m) | (65.8m) | (27.2m) | (16.0m) | (31.0m) | (24.3m) | (32.9m) |
Depreciation and Amortization | 436.0k | 136.0k | 288.0k | 448.0k | 317.0k | 726.0k | 1.2m | 456.0k | 972.0k | 1.5m | 616.0k | 1.3m | 2.0m | 842.0k | 1.8m |
Accounts Payable | (1.0m) | 1.1m | (158.0k) | 175.0k | 280.0k | (243.0k) | 361.0k | 352.0k | 538.0k | 402.0k | 1.2m | 1.2m | 3.0m | 745.0k | (2.0m) |
Cash From Operating Activities | 50.9m | (9.5m) | (19.2m) | (29.4m) | (14.3m) | (30.6m) | (46.5m) | 48.6m | 26.1m | 8.5m | 125.2m | 93.6m | 72.0m | (28.8m) | (50.0m) |
USD | Q3, 2015 |
---|---|
Financial Leverage | -3.5 x |
FY, 2016 | |
---|---|
Patent Applications | 28 |
Patents Issued | 157 |
When was Voyager Therapeutics founded?
Voyager Therapeutics was founded in 2014.
Who are Voyager Therapeutics key executives?
Voyager Therapeutics's key executives are Michael Higgins, Jim Geraghty and Glenn Pierce.
How many employees does Voyager Therapeutics have?
Voyager Therapeutics has 185 employees.
What is Voyager Therapeutics revenue?
Latest Voyager Therapeutics annual revenue is $171.1 m.
What is Voyager Therapeutics revenue per employee?
Latest Voyager Therapeutics revenue per employee is $925 k.
Who are Voyager Therapeutics competitors?
Competitors of Voyager Therapeutics include Taysha Gene Therapies, Watchmaker Genomics and New England Biolabs.
Where is Voyager Therapeutics headquarters?
Voyager Therapeutics headquarters is located at 75 Sidney St, Cambridge.
Where are Voyager Therapeutics offices?
Voyager Therapeutics has an office in Cambridge.
How many offices does Voyager Therapeutics have?
Voyager Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies